LeMaitre Vascular Inc. (LMAT) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.81	$0.74	-8.6%	—	$70.4M	—
Q1 26	$0.66	$0.68	+3.0%	—	$66.6M	—
Q4 25	$0.66	$0.68	+3.0%	—	$64.5M	—
Q3 25	$0.56	$0.75	+33.9%	—	$61M	—
Q2 25	$0.57	$0.6	+5.3%	—	$64.2M	—
Q1 25	$0.5	$0.48	-4.0%	—	$59.9M	—
Q4 24	$0.49	$0.49	0.0%	—	$55.7M	—
Q3 24	$0.43	$0.49	+14.0%	—	$54.8M	—
Q2 24	$0.47	$0.52	+10.6%	—	$55.8M	—
Q1 24	$0.39	$0.44	+12.8%	—	$53.5M	—
Q4 23	$0.36	$0.38	+5.6%	—	$48.9M	—
Q3 23	$0.3	$0.33	+10.0%	—	$47.4M	—
Q2 23	$0.32	$0.36	+12.5%	—	$50.1M	—
Q1 23	$0.25	$0.27	+8.0%	—	$47.1M	—
Q4 22	$0.26	$0.25	-3.8%	—	$41M	—
Q3 22	$0.28	$0.25	-10.7%	—	$39M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$2.55	—	—	$249.6M	—
FY24	—	$1.96	—	—	$219.9M	—
FY23	—	$1.36	—	—	$193.5M	—
FY22	—	$0.94	—	—	$161.7M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$89.2M	$100.9M	$105.6M	$117.2M	$129.4M	$154.4M	$161.7M	$193.5M	$219.9M	$249.6M
YoY change	+13.8%	+13.1%	+4.66%	+11%	+10.4%	+19.4%	+4.68%	+19.7%	+13.6%	+13.5%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	89.2M	100.9M	105.6M	117.2M	129.4M	154.4M	161.7M	193.5M	219.9M	249.6M
Cost of revenue	26.2M	30.2M	31.6M	37.4M	44.7M	53M	56.8M	66.4M	69M	71.1M
Gross profit	62.9M	70.7M	73.9M	79.9M	84.6M	101.4M	104.9M	127M	150.9M	178.5M
Gross margin	70.6%	70.1%	70%	68.1%	65.4%	65.7%	64.9%	65.7%	68.6%	71.5%
Research & development	6.1M	6.6M	8.2M	9.3M	10.1M	11.8M	13.3M	17M	15.7M	14.1M
Selling, general & administrative	40.5M	43M	45M	49.4M	46.2M	53.2M	61.7M	72.9M	83M	96.5M
Operating expenses	46.6M	49.6M	53.2M	58.7M	56.3M	65M	75M	89.9M	98.6M	110.6M
Operating income	16.3M	21.1M	20.7M	21.2M	28.3M	36.4M	29.9M	37.2M	52.3M	67.9M
Operating margin	18.3%	20.9%	19.6%	18.1%	21.9%	23.6%	18.5%	19.2%	23.8%	27.2%
Non-operating income, net	-161K	-155K	7.1M	-202K	141K	-116K	-3.4M	-799K	-125K	12.5M
Pretax income	16.2M	21.1M	28.4M	21.7M	27.4M	34.3M	27.5M	39.5M	56.9M	75.2M
Income tax	5.7M	3.9M	5.5M	3.7M	6.1M	7.4M	6.9M	9.4M	12.8M	17.4M
Net income	10.6M	17.2M	22.9M	17.9M	21.2M	26.9M	20.6M	30.1M	44M	57.7M
Net margin	11.9%	17%	21.7%	15.3%	16.4%	17.4%	12.8%	15.6%	20%	23.1%
EBITDA	20M	25.3M	25.7M	27.3M	36.6M	47.6M	40M	49.5M	66.8M	77.7M
EPS	0.57	0.91	1.18	0.91	1.05	1.27	0.94	1.36	1.96	2.55
Diluted EPS	0.55	0.86	1.13	0.88	1.04	1.25	0.93	1.34	1.93	2.52

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	47.4M	48.9M	53.5M	55.8M	54.8M	55.7M	59.9M	64.2M	61M	64.5M	66.6M	70.4M
Cost of revenue	16.6M	15.6M	16.8M	17.4M	17.6M	17.1M	18.5M	19.3M	15.1M	18.3M	18.2M	19.6M
Gross profit	30.8M	33.3M	36.7M	38.5M	37.2M	38.6M	41.4M	45M	46M	46.2M	48.4M	50.8M
Gross margin	65%	68.1%	68.6%	68.9%	67.8%	69.3%	69.2%	70%	75.3%	71.7%	72.7%	72.1%
Research & development	4.2M	4.4M	4.1M	4.3M	3.7M	3.6M	4.1M	3.5M	3M	3.5M	4.1M	4.8M
Selling, general & administrative	17.4M	18.7M	20.7M	19.8M	20.4M	22.1M	24.7M	25.3M	22.7M	23.8M	26.6M	25.5M
Operating expenses	21.6M	23.1M	24.8M	24.1M	24M	25.7M	28.8M	28.8M	25.6M	27.4M	30.6M	30.4M
Operating income	9.2M	10.2M	11.9M	14.4M	13.1M	12.9M	12.6M	16.1M	20.3M	18.8M	17.8M	20.4M
Operating margin	19.4%	20.9%	22.2%	25.7%	24%	23.1%	21.1%	25.1%	33.3%	29.2%	26.7%	29%
Non-operating income, net	-189K	115K	-78K	-11K	202K	-238K	2K	247K	-306K	12.5M	3.2M	-294K
Pretax income	9.8M	11.3M	12.8M	15.5M	14.6M	14M	14.2M	18.1M	22.6M	20.3M	19.7M	22.2M
Income tax	2.3M	2.8M	2.9M	3.7M	3.4M	2.8M	3.2M	4.3M	5.2M	4.7M	4M	5.1M
Net income	7.5M	8.5M	9.9M	11.8M	11.1M	11.2M	11M	13.8M	17.4M	15.6M	15.7M	17.1M
Net margin	15.8%	17.3%	18.5%	21.2%	20.3%	20.1%	18.4%	21.5%	28.4%	24.2%	23.6%	24.2%
EBITDA	11.8M	14.5M	14.3M	16.8M	15.4M	20.3M	18.1M	22M	26.5M	24.2M	20.3M	26.2M
EPS	0.34	0.38	0.44	0.53	0.5	0.5	0.49	0.61	0.77	0.69	0.69	0.75
Diluted EPS	0.33	0.38	0.44	0.52	0.49	0.49	0.48	0.6	0.75	0.68	0.68	0.74

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	468.4M	603.7M	459.2M	712.3M	820M	1.1B	1B	1.3B	2.1B	1.8B	1.9B
Enterprise value	444.1M	562.1M	411.2M	695.3M	847.8M	1B	945.2M	1.2B	2B	1.7B	1.7B
Shares outstanding	18.5M	19M	19.4M	19.8M	20.2M	21.2M	22M	22.2M	22.5M	22.6M	22.6M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	44.2	35.1	20	39.7	38.6	39.5	49	41.9	47	31.8	28.6
P/S	5.25	5.99	4.35	6.08	6.34	6.88	6.26	6.52	9.41	7.36	7.12
P/B	5.35	5.5	3.53	4.81	4.75	4.18	3.77	4.23	6.13	4.67	4.45
EV/EBITDA	22.2	22.2	16	25.5	23.2	21.2	23.6	23.8	29.3	21.4	20.2
EV/Sales	4.98	5.57	3.9	5.93	6.55	6.53	5.85	6.07	8.89	6.66	6.39
Earnings yield	2.26%	2.85%	5%	2.52%	2.59%	2.53%	2.04%	2.39%	2.13%	3.14%	3.5%
FCF yield	3%	2.72%	3.58%	1.46%	3.88%	2.84%	2.19%	2.34%	1.8%	4.06%	2.62%
PEG	—	—	—	—	—	—	—	—	—	—	1.25

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	70.6%	70.1%	70%	68.1%	65.4%	65.7%	64.9%	65.7%	68.6%	71.5%	72.1%
Operating margin	18.3%	20.9%	19.6%	18.1%	21.9%	23.6%	18.5%	19.2%	23.8%	27.2%	29%
Net margin	11.9%	17%	21.7%	15.3%	16.4%	17.4%	12.8%	15.6%	20%	23.1%	25%
ROE	12.1%	15.6%	17.6%	12.1%	12.3%	10.6%	7.69%	10.1%	13.1%	14.7%	16.8%
ROA	10.4%	13.6%	15%	9.52%	8.39%	9.19%	6.65%	8.68%	7.98%	9.38%	7.44%
ROIC	16.9%	25.2%	20.3%	13.4%	11%	14.3%	11.1%	13.4%	18.1%	23.7%	25.6%
Return on tangible assets	30%	27.6%	34.8%	30.6%	682.3%	48.5%	24.1%	22.9%	12.6%	13.8%	14.7%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	5.63	6.09	4.76	4.42	3.75	6.41	6.39	6.51	13.1	12.9	16.3
Quick ratio	4.01	4.63	3.46	2.76	2.19	4.55	4.6	4.76	11.3	11.3	14.4
Debt / equity	—	—	0	0.11	0.32	0.06	0.06	0.06	0.55	0.47	0.45
Debt / assets	—	—	0	0.08	0.22	0.05	0.05	0.06	0.34	0.3	0.3
Net debt / EBITDA	—	—	-1.87	-0.62	0.76	-1.14	-1.65	-1.74	-1.71	-2.23	-1.92
Interest coverage	1.2K	1K	14.2K	—	21.9	16.5	—	—	278.4	15.5	17.3
Effective tax rate	34.8%	18.6%	19.3%	17.3%	22.4%	21.5%	24.9%	23.7%	22.6%	23.2%	22.5%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	4.82	5.32	5.43	5.92	6.39	7.3	7.36	8.71	9.79	11	11.5
EPS (basic)	0.57	0.91	1.18	0.91	1.05	1.27	0.94	1.36	1.96	2.55	2.55
EPS (diluted)	0.55	0.86	1.13	0.88	1.04	1.25	0.93	1.34	1.93	2.52	2.86
Book value per share	4.73	5.79	6.7	7.48	8.52	12	12.2	13.4	15	17.4	18.4
FCF per share	0.76	0.87	0.85	0.53	1.57	1.43	1.01	1.33	1.66	3.29	3.01
Cash per share	1.31	2.2	2.47	1.65	1.33	3.31	3.76	4.73	13.3	15.9	16.5
Capex per share	0.15	0.34	0.16	0.19	0.05	0.23	0.11	0.33	0.31	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	3.19%	6.36%	2.89%	3.21%	0.74%	3.16%	1.47%	3.75%	3.17%	—	—
Capex / operating cash flow	19.1%	28.4%	11.7%	27.3%	2.88%	14.9%	10%	19.5%	16.5%	—	—
Payout ratio	31.4%	24.3%	23.7%	37.6%	36.3%	34.7%	53.2%	41.3%	32.6%	31.4%	31.5%
Dividend yield	0.71%	0.69%	1.19%	0.95%	0.94%	0.88%	1.09%	0.99%	0.7%	0.99%	1.21%

Yield

1.21%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.25

ex-dividend Aug 20, 2026

Payout ratio

31%

of earnings

Dividend growth

12 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 20, 2026	$0.25
May 21, 2026	$0.25
Mar 12, 2026	$0.25
Nov 20, 2025	$0.20
Aug 21, 2025	$0.20

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$47.4M	$48.9M	$53.5M	$55.8M	$54.8M	$55.7M	$59.9M	$64.2M	$61M	$64.5M	$66.6M	$70.4M
YoY change	+21.5%	+19.4%	+13.6%	+11.4%	+15.6%	+14%	+12%	+15%	+11.4%	+15.7%	+11.2%	+9.57%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	24.3M	41.7M	48M	32.7M	27M	70M	82.7M	105.1M	299.7M	359.1M
Receivables	13.2M	15M	15.7M	16.6M	19.6M	19.6M	22M	25.1M	30.1M	33.6M
Inventory	17M	19.2M	25.6M	34.6M	39.2M	40.6M	45.3M	52.3M	55.9M	58.2M
Total current assets	59M	80.3M	94M	92.1M	94.3M	139.9M	161.7M	194.6M	402.2M	468.2M
Property, plant & equipment	8M	12.4M	14.1M	30.1M	31.1M	32.1M	33.5M	39.8M	41.6M	42.8M
Goodwill & intangibles	66.6M	64.2M	87.1M	129.7M	249.7M	237.3M	224.9M	215.3M	203.5M	198.1M
Total assets	101.9M	126.3M	153.1M	188.3M	252.8M	292.8M	310.5M	346.8M	551.8M	615.7M
Accounts payable	1.2M	1.5M	1.7M	2.6M	2.4M	2.3M	2.9M	3.7M	1.8M	3.6M
Short-term debt	—	—	—	1.8M	4.5M	1.9M	1.9M	2.5M	2.7M	2.9M
Total current liabilities	10.5M	13.2M	19.8M	20.9M	25.1M	21.8M	25.3M	29.9M	30.6M	36.3M
Long-term debt	—	—	0	14M	50.3M	14.1M	14.7M	16.6M	183M	182.6M
Total liabilities	14.4M	16.6M	22.9M	40.2M	80.2M	38.7M	42.3M	48.9M	214.5M	222.2M
Shareholders' equity	87.5M	109.8M	130.2M	148.1M	172.6M	254.2M	268.2M	297.9M	337.3M	393.5M
Total debt	—	—	0	15.7M	54.8M	15.9M	16.6M	19.1M	185.7M	185.6M
Net debt	—	—	-26.3M	3.9M	28M	2.1M	-2.5M	-5.2M	160.1M	157.3M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	97M	105.1M	108.3M	113.1M	123.9M	299.7M	302.5M	319.5M	343.1M	359.1M	367.2M	376.2M
Receivables	23.9M	25.1M	30.2M	30.8M	32.3M	30.1M	35.1M	36.5M	32.4M	33.6M	35.8M	35.7M
Inventory	51.3M	52.3M	54.5M	56.7M	57.1M	55.9M	56M	57.5M	58.9M	58.2M	57.8M	57.9M
Total current assets	182.2M	194.6M	203M	212.8M	227.1M	402.2M	408.1M	430.1M	452M	468.2M	477.8M	488.3M
Property, plant & equipment	37.2M	39.8M	40M	40.4M	41.1M	41.6M	41.3M	41.9M	42.5M	42.8M	48.4M	49.6M
Goodwill & intangibles	218.3M	215.3M	212.4M	209.4M	206.5M	203.5M	200.7M	198.2M	195.3M	198.1M	195.2M	193M
Total assets	334M	346.8M	354M	363.1M	377M	551.8M	556M	577.6M	598.1M	615.7M	629.5M	640.5M
Accounts payable	4.4M	3.7M	3.1M	2M	1.7M	1.8M	2.2M	4.9M	3.5M	3.6M	4.2M	3.2M
Short-term debt	2.7M	2.5M	2.5M	2.6M	2.7M	2.7M	2.6M	2.8M	2.8M	2.9M	3.4M	3.4M
Total current liabilities	29M	29.9M	26.8M	25.4M	29.3M	30.6M	24.7M	30.8M	33.3M	36.3M	33.4M	29.9M
Long-term debt	14.1M	16.6M	16.4M	15.8M	15.6M	183M	182.7M	183.1M	182.8M	182.6M	186.4M	186.8M
Total liabilities	45.4M	48.9M	45.5M	43.5M	46M	214.5M	208.4M	214.9M	219.1M	222.2M	222.9M	220.2M
Shareholders' equity	288.6M	297.9M	308.5M	319.5M	331.1M	337.3M	347.6M	362.7M	378.9M	393.5M	406.6M	420.3M
Total debt	16.9M	19.1M	18.9M	18.4M	18.3M	185.7M	185.4M	185.9M	185.6M	185.6M	189.8M	190.3M
Net debt	-1.2M	-5.2M	-7.7M	-3.9M	-2.7M	160.1M	160M	158.7M	160.1M	157.3M	163M	163.6M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	10.6M	17.2M	22.9M	17.9M	21.2M	26.9M	20.6M	30.1M	44M	57.7M
Depreciation & amortization	3.6M	4.1M	4.3M	5.4M	8.4M	11.1M	9.4M	9.5M	9.7M	10.4M
Stock-based compensation	1.7M	2.3M	2.3M	2.6M	3M	3.5M	4.2M	5.3M	6.6M	7.8M
Change in working capital	-1.2M	-1.3M	-1.2M	-13.2M	774K	-8M	-10.3M	-8.3M	-17.8M	-6M
Operating cash flow	14.8M	22.6M	26.2M	13.8M	33.3M	32.8M	23.6M	37.3M	42.2M	81.3M
Capital expenditure	-2.8M	-6.4M	-3.1M	-3.8M	-959K	-4.9M	-2.4M	-7.3M	-7M	—
Investing cash flow	-17.2M	-29M	-7.1M	-24.1M	-52.9M	-61.1M	-10.4M	-24.7M	-200.1M	-58.2M
Dividends paid	-3.3M	-4.2M	-5.4M	-6.7M	-7.7M	-9.3M	-11M	-12.4M	-14.4M	-18.1M
Share repurchases	-311K	-778K	-741K	-683K	-570K	-802K	-642K	—	—	—
Financing cash flow	-2.6M	80K	-4.4M	-4.6M	7.2M	13.7M	-9.2M	-6.3M	159.8M	-19.5M
Net change in cash	-4.9M	-6.3M	14.7M	-15M	-12.5M	-14.6M	4M	6.3M	1.9M	3.6M
Free cash flow	14.1M	16.5M	16.5M	10.4M	31.8M	30.2M	22.1M	29.5M	37.2M	74.5M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	7.5M	8.5M	9.9M	11.8M	11.1M	11.2M	11M	13.8M	17.4M	15.6M	15.7M	17.1M
Depreciation & amortization	2.4M	2.4M	2.4M	2.4M	2.4M	2.5M	2.6M	2.6M	2.6M	2.6M	2.6M	2.7M
Stock-based compensation	1.3M	1.4M	1.6M	1.6M	1.6M	1.7M	2M	1.9M	1.7M	2.1M	2.1M	1.9M
Change in working capital	2.1M	-924K	-12.1M	-6M	-791K	1.1M	-11.2M	1.2M	7.1M	-3.1M	-6.2M	-5.1M
Operating cash flow	13.2M	11.4M	1.8M	9.8M	14.4M	16.6M	5.7M	20.3M	28.8M	23.2M	15.1M	16M
Capital expenditure	-1.1M	-1.3M	-1.4M	-1.9M	-1.7M	-2M	-1.4M	—	—	—	—	—
Investing cash flow	-9.9M	-2.3M	-2.4M	-11M	-12.9M	-258.7M	-4.3M	-15M	-25.2M	-600.1M	-10.3M	-8.8M
Dividends paid	-3.1M	-3.1M	-3.6M	-3.6M	-3.6M	-3.6M	-4.5M	-4.5M	-4.5M	-4.5M	-5.7M	-5.7M
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-3.1M	-2M	-3.6M	-3.6M	-3.6M	-3.6M	-6M	-4.5M	-4.5M	-4.5M	-5.7M	-5.7M
Net change in cash	237K	7.1M	-4.1M	-4.8M	-2M	-245.7M	-4.6M	764K	-937K	-581.5M	-956K	1.5M
Free cash flow	10.8M	9.5M	3.7M	7.7M	12.6M	13.1M	7.7M	18.9M	26.5M	21.4M	12.3M	13.7M

LeMaitre Vascular Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement